Ginkgo Biloba Extract (EGb 761) and CNS Functions: Basic Studies and Clinical Applications

Current Drug Targets

Volumn 1, Issue 1, 2000, Pages 25-58

  DeFeudis, F V ^a   Drieu, K ^b  

^a Institute for BioScience   (United States)

^b Institut Henri Beaufour   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLAVONOID; GINKGO BILOBA EXTRACT 761; NITRIC OXIDE; PLANT EXTRACT;

ALZHEIMER DISEASE; ANIMAL; APOPTOSIS; BRAIN CIRCULATION; DRUG EFFECT; GINKGO BILOBA; HUMAN; MEMORY; MITOCHONDRION; NERVE CELL PLASTICITY; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; PHYSIOLOGY; REVIEW; STRESS;

ALZHEIMER DISEASE; ANIMALS; APOPTOSIS; CEREBROVASCULAR CIRCULATION; FLAVONOIDS; GINKGO BILOBA; HUMANS; MEMORY; MITOCHONDRIA; NEURONAL PLASTICITY; NITRIC OXIDE; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; PLANT EXTRACTS; STRESS;

EID: 0034232147     PISSN: 13894501     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389450003349380     Document Type: Article

References (166)

1. Foster, S., Chongxi, Y. (1992) Herbal Emissaries. Healing Arts Press, Rochester, Vermont.
2. Drieu, K. (1988) in Rökan, Ginkgo Biloba: Recent Results in Pharmacology and Clinic (E. W. Fünfgeld, Ed.), pp. 32-36. Springer-Verlag, Berlin.
3. DeFeudis, F. V. (1991) Ginkgo Biloba Extract (EGb 761): Pharmacological Activities and Clinical Applications. Elsevier, Paris.
4. Jaggy, H. (1993) Hämostaseologie, 13, 7-10.
5. Middleton, E., Jr. and Kandaswami, C. (1993) in The Flavonoids: Advances in Research Since 1986. (Harborne, J. B., Ed.), pp. 619-652 (Chapt. 15), Chapman & Hall, London.
6. Brown, J. P. (1980) Mutation Res. 75, 243-277.
7. Swain, T. (1962) in The Chemistry of Flavonoid Compounds (Geissman, T. A., Ed.), pp. 513-552. Pergamon Press, London.
8. Remesy, C., Manach, C., Demigne, C., Texier, O. and Regerat, F. (1996) Méd. et Nutr. 32, 17-27.
9. Havsteen, B. (1983) Biochem. Pharmacol. 32, 1141-1148.
10. Hackett, A. M. (1986). in Progress in Clinical and Biological Research, Vol. 213. Plant Flavonoids in Biology and Medicine: Biochemical, Pharmacological, and Structure-Activity Relationships (V. Cody, E. Middleton and J. B. Harborne, Eds.), pp. 177-194. Alan R. Liss, New York.
11. Watson, D. G. and Pitt, A. R. (1998) Rapid Commun. Mass Spectrom. 12, 153-156.
12. Pietta, P. G., Gardana, C., Mauri, P. L., Maffei-Facino, R. and Carini, M. (1995) J. Chromatogr. B: Biomed. Sci. Appl. 673, 75-80.
13. Pietta, P. G., Gardana, C. and Mauri, P. L. (1997) J. Chromatogr. B: Biomed. Sci. Appl. 693, 249-255.
14. Manach, C., Morand, C., Crespy, V., Demigne, C., Texier, O., Regerat, F. and Remesy, C. (1998) FEBS Lett. 426, 331-336.
15. Watson, D. G. and Oliveira, E. J. (1999) J. Chromatogr. B: Biomed. Sci. Appl. 723, 203-210.
16. Schwarz, M. and Arigoni, D. (1999) in Comprehensive Natural Products Chemistry. Vol. 2. Isoprenoids Including Carotenoids and Steroids, pp. 367-400. Pergamon Elsevier Science, London.
17. Fourtillan, J. B., Brisson, A. M., Girault, J., Ingrand, I., Decourt, J. P., Drieu, K., Jouenne, P. and Biber, A. (1995) Thérapie, 50, 137-144.
18. Biber, A and Koch, E. (1999) Planta Medica, 65, 192-193.
19. BGA-Kommission E. (1994) Monographie: Trockenextrakt (35-67:1) aus Ginkgo-biloba-Blättern, extrahiert mit Aceton-Wasser. Bundesanzeiger (Banz.), No. 133, p. 7361, July 19, 1994.
20. VIDAL (1995) 71st Edition, Editions du Vidal, Paris, pp. 1444-1445.
21. DeFeudis, F. V. (1998) Ginkgo Biloba Extract (EGb 761) - From Chemistry to the Clinic. Ullstein-Mosby, Wiesbaden.
22. Kleijnen, J., Knipschild, P. (1992a) Lancet, 340,1136-1139.
23. Kleijnen, J., Knipschild, P. (1992b) Br. J. Clin. Pharmacol. 34, 352-358.
24. Oken, B. S., Storzbach, D. M. and Kaye, J. A. (1998) Arch. Neurol. 55, 1409-1415.
25. Drieu, K. and DeFeudis, F. V. (2000) in Ginkgo biloba: Medicinal and Aromatic Plants: Industrial Profiles (T. A. van Beek, Ed.). Harwood Academic Publishers, Amsterdam. pp. 303-329.
26. DeFeudis, F. V. and Drieu, K. (2000) in Ginkgo biloba: Medicinal and Aromatic Plants: Industrial Profiles (T. A. van Beek, Ed.). Harwood Academic Publishers, Amsterdam, pp. 279-301.
27. Ernst, E. and Pittler, M. H. (1999) Clin. Drug Invest. 17, 301-308.
28. Taylor, J. E. (1990) Soc. Neurosci. Annual Meeting, St. Louis (Abstract No. 32.11).
29. Taylor, J. E., Odell, A. and Bonin, A. (1991) Biomeasure, Inc., Internal Report, No. 288-4, 12 pp.
30. Ramassamy, C., Christen, Y., Clostre, F. and Costentin, J. (1992a) J. Pharm. Pharmacol. 44, 943-945.
31. Whitton, P. S., Sarna, G. S., O'Connel, M. T. and Curzon, G. (1991) Neuropharmacology, 30, 1-4.
32. Ramassamy, C., Christen, Y., Clostre, F. and Costentin, J. (1993a) in Ginkgo biloba Extract (EGb 761) as a Free-Radical Scavenger (Ferradini, C., Droy-Lefaix, M. T. and Christen, Y., Eds.), pp. 39-50. Elsevier, Paris.
33. Ramassamy, C., Girbe, F., Christen, Y. and Costentin, J. (1993b) Free Rad. Res. Commun. 19, 341-350.
34. Stoll, S., Scheuer, K., Pohl, O. and Müller, W. E. (1996) Pharmacopsychiatry, 29, 144-149.
35. Pietri, S., Maurelli, E., Drieu, K. and Culcasi, M. (1997) J. Mol. Cell. Cardiol. 29, 733-742.
36. Ni, Y., Zhao, B., Hou, J. and Xin, W. (1996) Neurosci. Lett. 214, 115-118.
37. Chen, C., Wei, T., Gao, Z., Zhao, B., Hou, J., Xu, H., Xin, W. and Packer, L. (1999) Biochem. Mol. Biol. Int. 47, 397-405.
38. Rapin, J. R., Zaibi, M. and Drieu, K. (1998) Drug Dev. Res. 45, 23-29.
39. Ahlemeyer, B., Möwes, A. and Krieglstein, J. (1999) Eur. J. Pharmacol. 367, 423-430.
40. Didier, A., Rouiller, D., Coronas, V., Jourdan, F. and Droy-Lefaix, M. T. (1996) in Advances in Ginkgo biloba Extract Research, vol. 5. Effects of Ginkgo biloba Extract (EGb 761) on Neuronal Plasticity (Y. Christen, M. T. Droy-Lefaix and J. F. Macias-Nuñez, Eds.), pp. 45-52. Elsevier, Paris.
41. Braughler, J. M. and Hall, E. D. (1992) J. Neurotrauma, 9, S1-S7.
42. Thompson, C. B. (1995) Science, 267, 1456-1462.
43. DeFeudis, F. V. (1992) Drug News Perspect. 5, 361-363.
44. DeFeudis, F. V. (1995) Gen. Pharmacol. 26, 667-680.
45. Dawson, V. L. and Dawson, T. M. (1996) J. Chem. Neuroanat. 10, 179-190.
46. Goureau, O. and Courtois, Y. (1995) in Advances in Ginkgo biloba Extract Research, Vol. 4. Effects of Ginkgo biloba Extract (EGb 761) on Aging and Age-Related Disorders (Christen, Y., Courtois, Y. and Droy-Lefaix, M. T., Eds.), pp. 65-69. Elsevier, Paris.
47. Bastianetto, S., Ramassamy, C., Christen, Y., Poirier, J. and Quirion, R. (1998) in Advances in Ginkgo biloba Extract Research. Vol. 7, Ginkgo biloba Extract (EGb 761): Lessons from Cell Biology (Packer, L. and Christen, Y., Eds.), pp. 85-99. Elsevier, Paris.
48. Chandrasekaran, K., Liu, L. -I., Hatanpää, K., Drieu, K. and Rapoport, S. I. (1998) in Advances in Ginkgo biloba Extract Research, Vol. 7. Ginkgo biloba Extract (EGb 761): Lessons from Cell Biology (L. Packer and Y. Christen, Eds.), pp. 121-128. Elsevier, Paris.
49. Spinnewyn, B., Blavet, N. and Drieu, K. (1995) in Advances in Ginkgo biloba Extract Research, Vol. 4. Effects of Ginkgo biloba Extract (EGb 761) on Aging and Age-Related Disorders (Christen, Y., Courtois, Y. and Droy-Lefaix, M. T., Eds.), pp. 17-22. Elsevier, Paris.
50. Janssens, D., Michiels, C., Delaive, E., Eliaers, F., Drieu, K. and Remade, J. (1995) Biochem. Pharmacol. 50, 991-999.
51. Janssens, D., Remacle, J. Drieu, K. and Michiels, C. (1999) Biochem. Pharmacol. 57, In press.
52. Chandrasekaran, K., Giordano, T., Brady, D. R., Stoll, J., Martin, L. J. and Rapoport, S. I. (1994) Mol. Brain Res. 24, 336-340.
53. Chandrasekaran, K., Hatanpää, K., Brady, D. R. and Rapoport, S. I. (1996) Exp. Neurol. 142, 80-88.
54. Poirier, J., Davignon, J., Bouthillier, D., Kogan, S., Bertrand, P. and Gauthier, S. (1993) Lancet, 342, 697-699.
55. Strittmatter, W. J., Saunders, A. M., Schmechel, D. E., Pericak-Vance, M. A., Enghild, J., Salvesen, G. S. and Roses, A. D. (1993) Proc. Natl. Acad. Sci. U.S.A. 90, 1977-1981.
56. Ramassamy, C., Krzywkowski, P., Bastianetto, S., Averill, D., Christen, Y., Quirion, R. and Poirier, J. (1998) in Advances in Ginkgo biloba Extract Research. Vol. 7, Ginkgo biloba Extract (EGb 761): Lessons from Cell Biology (Packer, L. and Christen, Y., Eds.) pp. 69-83. Elsevier, Paris.
57. Krieglstein, J., Beck, T. and Seibert, A. (1986) Life Sci. 39, 2327-2334.
58. Rapin, J. R. and Le Poncin Lafitte, M. (1986) Presse Méd. 15, 1494-1497.
59. Lamour, Y., Holloway, H. W., Rapoport, S. I. and Soncrant, T. T. (1992) in Effects of Ginkgo biloba Extract (EGb 761) on the Central Nervous System (Christen, Y., Costentin, J. and Lacour, M., Eds.), pp. 19-25. Elsevier, Paris.
60. Duverger, D., DeFeudis, F. V. and Drieu, K (1995) Gen. Pharmacol. 26, 1375-1383.
61. Delaflotte, S., Auguet, M., DeFeudis, F. V., Baranes, J., Clostre, F., Drieu, K. and Braquet, P. (1984) Biomed. Biochim. Acta, 43 (Suppl.), 212-216.
62. Stücker, O., Pons, C., Duverger, J. P. and Drieu, K. (1996) Int. J. Microcirc. 16, 98-104.
63. Reiman, E. M., Caselli, R. J., Yun, L. -S., Chen, M. S., Bandy, D., Minoshima, S., Thibodeau, S. N. and Osborne, D. (1996) New Engl. J. Med. 334, 752-758.
64. Mattson, M. P. (1995) Aging, 16, 679-682.
65. Amri, H., Ogwuegbu, S. O., Boujrad, N., Drieu, K. and Papadopoulos, V. (1996) Endocrinology, 137, 5707-5718.
66. Beck, T., Abdel-Rahman, M. M., Bielenberg, G. W., Oberpichler, H. and Krieglstein, J. (1986) in Pharmacology of Cerebral Ischemia (J. Krieglstein, Ed.), pp. 345-350. Elsevier, Amsterdam.
67. Spinnewyn, B., Blavet, N. and Clostre, F. (1986) Press Méd. 15, 1511-1515.
68. Spinnewyn, B. (1992) in Effects of Ginkgo biloba Extract (EGb 761) on the Central Nervous System (Christen, Y., Costentin, J. and Lacour, M. Eds.), pp. 113-118. Elsevier, Paris.
69. Spinnewyn, B., Blavet, N., Clostre, F., Bazan, N. G. and Braquet, P. (1987) Prostaglandins, 34, 337-348.
70. Zalewska, T., Zablocka, B. and Domanska-Janik, K. (1996) Acta Neurobiol. Exp. 56, 41-48.
71. Sancesario, G. and Kreutzberg, G. W. (1986) Acta Neuropath. 72, 3-14.
72. Chatterjee, S. S., Gabard, B. L. and Jaggy, H. E. W. (1986) U. S. Patent No. 4,571,407 (Feb. 18, 1986).
73. Dorman, D. C., Côté, L. M. and Buck, W. B. (1992) Amer. J. Vet. Res. 53, 138-142.
74. Borzeix, M. G., Labos, M. and Hartl, C. (1980) Sem. Hôp. Paris, 56, 393-398.
75. Klein, J., Chatterjee, S. S. and Löffelholz, K. (1997) Brain Res. 755, 347-350.
76. Taylor, J. E. (1986) Presse Méd. 15, 1491-1493.
77. Kristofikova, Z., Benesova, O. and Tejkalova, H. (1992) Dementia, 3, 304-307.
78. Huguet, F. and Tarrade, T. (1992) J. Pharm. Pharmacol. 44, 24-27.
79. Huguet, F., Drieu, K. and Piriou, A. (1994) J. Pharm. Pharmacol. 46, 316-318.
80. Dillon, K. A., Gross-Isseroff, R., Israeli, M. and Biegon, A. (1991) Brain Res. 554, 56-64.
81. Harman, D. (1996) Ann. N. Y. Acad. Sci. 786, 152-168.
82. Sastre, J., Millan, A., Garcia, J., de la Asuncion, J. G., Pla, R., Juan, G., Pallardo, V., O'Connor, E., Martin, J. A., Droy-Lefaix, M. T. and Vina, J. (1998) Free Rad. Biol. Med. 24, 298-304.
83. Winter, E. (1991) Pharmacol. Biochem. Behav. 38, 109-114.
84. Blavet, N. (1992) in Effects of Ginkgo biloba Extract (EGb 761) on the Central Nervous System (Y. Christen, J. Costentin and M. Lacour, Eds.), pp. 119-127. Elsevier, Paris.
85. Michalek, H., Fortona, S. and Pintor, A. (1989) Neurobiol. Aging, 10, 143-148.
86. Lamprogou, I,. Boisserie, G., Vranck, R., Baillet, F., Bok, B. and Drieu, K. (1997) in Advances in Ginkgo biloba Extract Research, vol. 6. Adaptive Effects of Ginkgo biloba Extract (EGb 761) (Papadopoulos, V., Drieu, K. and Christen, Y., Eds.), pp. 73-87. Elsevier, Paris.
87. Winter, J. C. (1998) Physiol. Behav. 63, 425-433.
88. Winter, J. C. and Timineri, D. (1999) Pharmacol. Biochem. Behav. 62, 543-547.
89. Attella, M. J., Hoffman, S. W., Stasio, M. J. and Stein, D. J. (1989) Exp. Neurol. 105, 62-71.
90. Stein, D. G. and Hoffman, S. W. (1992) in Effects of Ginkgo biloba Extract (EGb 761) on the Central Nervous System (Christen, Y., Costentin, J. and Lacour, M., Eds.), pp. 95-103. Elsevier, Paris.
91. Brailowsky, S., Montiel, T., Hernández-Echeagaray, E., Flores-Hernández, J. and Hernández-Pineda, R. (1991) Restor. Neurol. Neurosci. 3, 267-274.
92. Brailowsky, S., Montiel, T., Hernández-Echeagaray, E., Flores-Hernández, J. and Hernández-Pineda, R. (1992) in Effects of Ginkgo biloba Extract (EGb 761) on the Central Nervous System (Y. Christen, J. Costentin and M. Lacour, Eds.), pp. 105-112. Elsevier, Paris.
93. Brailowsky, S., Montiel, T. and Medina-Ceja, L. (1993) Soc. Neurosci. Abstr. 19, 1013 (Abstr. No. 414.8).
94. Brailowsky, S., Montiel, T. and Medina-Ceja, L. (1995) Restor. Neurol. Neurosci. 8, 163-167.
95. Shifman, M. I., Fulop, Z. L., Hashemzadeh-Gargari, H. and Stein, D. G. (1996) in Advances in Ginkgo biloba Extract Research, vol. 5. Effects of Ginkgo biloba Extract (EGb 761) on Neuronal Plasticity (Christen, Y., Droy-Lefaix, M. T. and Macias-Nuñez, J. F., Eds.), pp. 61-74. Elsevier, Paris.
96. Barkats, M., Venault, P., Christen, Y. and Cohen-Salmon, C. (1995) Life Sci. 56, 213-222.
97. Amenta, F., Jaton, A. -L. and Ricci, A. (1990) Arch. Gerontol. Geriatr. 12, 287-296.
98. Cohen-Salmon, C., Pardon, M. C., Venault, P. and Christen, Y. (1995) Soc. Neurosci. Abstr. 21 (Part 1), 165 (Abstr. No. 71.7).
99. Lupien, S.J., de Leon, M., de Santi, S., Convit, A., Tarshish, C., Nair, N. P., Thakur, M., McEwen, B. S., Hauger, R. L., Meaney, M. J. (1998) Nature Neurosci. 1, 69-73.
100. Porsolt, R. D., Martin, P., Lenègre, A., Fromage, S. and Drieu, K. (1990) Pharmacol. Biochem. Behav. 36, 963-971.
101. Porsolt, R. D., Martin, P., Fromage, S., Lenègre, A. and Drieu, K. (1992) in Advances in Ginkgo biloba Extract Research. Vol. 1, Effects of Ginkgo biloba Extract (EGb 761) on the Central Nervous System. (Christen, Y., Costentin, J. and Lacour, M., Eds.) pp. 135-145. Elsevier, Paris.
102. Rapin, J. R., Lamproglou, I., Drieu, K. and DeFeudis, F. V. (1994) Gen. Pharmacol. 25, 1009-1016.
103. Marcilhac, A., Dakine, N., Bourhim, N., Guillaume, V., Grino, M., Drieu, K. and Oliver, C. (1998) Life Sci. 62, 2329-2340.
104. Rapin, J. R., Noblet, C. and Drieu, K. (1999) Gen. Pharmacol. Submitted.
105. Chermat, R., Brochet, D., DeFeudis, F. V. and Drieu, K. (1997) Pharmacol. Biochem. Behav. 56, 333-339.
106. File, S. E. and Baldwin, H. A. (1987) Brain Res. Bull. 19, 293-299.
107. DeFeudis, F. V. (1990) Ann. N.Y. Acad. Sci. 585, 231-240.
108. Brochet, D., Chermat, R., DeFeudis, F. V. and Drieu, K. (1999) Gen. Pharmacol. 33, 249-256.
109. Manocha, A., Pillai, K. K. and Husain, S. Z. (1997) Indian J. Pharmacol. 29, 198-200.
110. Rapin, J. R., Provost, P. and Drieu, K. (1997) in Advances in Ginkgo biloba Extract Research, vol. 6. Adaptive Effects of Ginkgo biloba Extract (EGb 761) (Papadopoulos, V., Drieu, K. and Christen, Y., Eds.), pp. 129-138. Elsevier, Paris.
111. Trovero, F., Brochet, D., Tassin, J. -P. and Drieu, K. (1999) Brain Res. 818, 135-139.
112. Sharma, H. S., Westman, J., Nyberg, F., Cervós-Navarro, J. and Dey, P. K. (1994) in Thermal Balance in Health and Disease: Advances in Pharmacological Sciences. pp. 461-467. Birkhäuser Verlag, Basel.
113. Sharma, H. S., Drieu, K., Alm, P. and Westman, J. (1999) XI Pharmacology of Thermoregulation, Sevilla, May 9-13, 1999; J. Thermal Biol. pp. 1-6.
114. Sharma, H. S., Drieu, K., Alm, P. and Westman, J. (1999) XI Pharmacology of Thermoregulation, Sevilla, May 9-13, 1999; J. Thermal Biol. pp. 1-6.
115. Bolanos-Jiménez, F., Manhaes de Castro, R., Sarhan, H., Prudhomme, N., Drieu, K. and Fillion, G. (1995) Fundam. Clin. Pharmacol. 9, 169-174.
116. Orrell, M. W. and O'Dwyer, A. -M. (1995) Lancet, 345, 666-667.
117. Oliver, C., Guillaume, V., Héry, F., Bourhim, N., Boiteau, K. and Drieu, K. (1994) Eur. J. Endocrinol. 130 (Suppl. 2), 207 (Abstr. No. P3.072).
118. Papadopoulos, V., Widmaier, E. P., Amri, H., Zilz, A., Li, H., Culty, M., Castello, R., Philip, G. H., Sridaran, R. and Drieu, K. (1998) Endocr. Res. 24, 479-487.
119. Amri, H., Drieu, K. and Papadopoulos, V. (1997) Endocrinology, 138, 5415-5426.
120. Lupien, S. J., Gaudreau, S., Tchiteya, B. M., Maheu, F., Sharma, S., Nair, N. P., Hauger, R. L., McEwen, B. S., Meaney, M. J. (1997) Clin. Endocrinol. Metab. 82, 2070-2075.
121. Lupien, S., Lecours, A. R., Lussier, I., Schwartz, G., Nair, N. P. and Meaney, M. J. (1994) J. Neurosci. 14, 2893-2903.
122. Lupien, S. J. and McEwen, B. S. (1997) Brain Res. Rev. 24, 1-27.
123. Allard, M. (1986) Presse Méd. 15, 1540-1545.
124. Warburton, D. M. (1986) Presse Méd. 15, 1595-1604.
125. Letzel, H., Haan, J. and Feil, W. B. (1996) J. Drug Dev. Clin. Pract. 8, 77-94.
126. Drieu, K. (1986) Presse Méd. 15, 1455-1457.
127. Hofferberth, B. (1994) Human Psychopharmacol. 9, 215-222.
128. Hachinski, V. C., Iliff, L. D., Zilhka, E., Du Boulay, G. H., McAllister, V. L., Marshall, J., Russell, R. W. R. and Symon, L. (1975) Arch. Neurol. 32, 632-637.
129. Menges, K. (1992) Pharmacopsychiatry, 25, 126-135.
130. Small, G. W., Rabins, P. V., Barry, P. P. et al. (1997) JAMA, 278, 1363-1371.
131. Tea, S., Celsis, P., Clanet, M. and Marc-Vergnes, J. (1979) Gaz. Méd. (France), 86, 4149-4152.
132. Eckmann, F. and Schlag, H. (1982) Fortschr. Med. 100, 1474-1478.
133. Vorberg, G. (1985) Clin. Trials Journal, 22, 149-157.
134. Brage, D. (1986) La Semana Médica, 169, 381-384.
135. Gerhardt, G., Rogalla, K. and Jaeger, J. (1990) Fortschr. Med. 108, 384-388.
136. Taillandier, J., Ammar, A., Rabourdin, J. P., Ribeyre, J. P., Pichon, J., Niddam, S. and Pierart, H. (1986) Presse Méd. 15, 1583-1587.
137. Halama, P., Bartsch, G. and Meng, G. (1988) Fortschr. Med. 106, 408-412.
138. Wesnes, K., Simmons, D., Rook, M. and Simpson, P. (1987) Human Psychopharmacology, 2, 159-169.
139. Gräßel, E. (1992) Fortschr. Med. 110, 73-76.
140. Hofferberth, B. (1989) Arzneim.-Forsch./Drug Res. 39, 918-922.
141. Künkel, H. (1994) Neuropsychobiology, 27, 40-45.
142. Luthringer, R., d'Arbigny, P. and Machler, J.P. (1995) in Advances in Ginkgo biloba Extract Research, Vol. 4. Effects of Ginkgo biloba Extract (EGb 761) on Aging and Age-Related Disorders (Christen, Y., Courtois, Y. and Droy-Lefaix, M. T., Eds.), pp. 107-118. Elsevier, Paris.
143. Itil, T. and Martorano, D. (1995) Psychopharmacol. Bull. 31, 147-158.
144. Itil, T. M., Erlap, E., Tsambis, E., Itil, K. Z. and Stein, U. (1996) Amer. J. Therapeut. 3, 63-73.
145. Allain, H., Raoul, P., Lieury, A., LeCoz, F., Gandon, J. M. and d'Arbigny, P. (1993) Clin. Ther. 15, 549-558.
146. Weitbrecht, W. V. and Jansen, W. (1986) Fortschr. Med. 104, 199-202.
147. Kanowski, S., Herrmann, W. M., Stephan, K., Wierich, W. and Hörr, R. (1996) Pharmacopsychiatry, 29, 47-56.
148. Le Bars, P. L., Katz, M. M., Berman, N., Itil, T. M., Freedman, A. M. and Schatzberg, A. F. (1997) JAMA, 278, 1327-1332.
149. CPMP Working Party on Efficacy of Medicinal Products (1992): Note for guidance. Antidementia medicinal products. Commission of the European Communities, Brussels, III/3705-91 EN, Draft 5.
150. Weiss, H. and Kallischnigg, G. (1991) Münch. Med. Wschr. 133, 138-142.
151. Meyer, B. (1986) Presse Méd. 15, 1562-1564.
152. Haguenauer, J. P., Cantenot, F., Koskas, H. and Pierart, H. (1986) Presse Méd. 15, 1569-1572.
153. Vorberg, G., Schenk, N. and Schmidt, U. (1989) Herz + Gefäße, 9, 936-941.
154. Eckmann, F. (1990) Fortschr. Med. 108, 557-560.
155. Schmidt, U., Rabinovici, K. and Lande, S. (1991) Med. Wochenschr. 133 (Suppl. 1), S15-S18.
156. Brückert, E., Heinrich, S. E., Ruf-Kohler, P. (1991) Münch. Med. Wochenschr. 133 (Suppl. 1), 9-14.
157. Rogers, S. L., Farlow, M. R., Doody, R. S., Mohs, R. and Friedhoff, L. T. (1998) Neurology, 50, 136-145.
158. Halama, P. (1991) Münch. Med. Wochenschr. 133 (Suppl. 1), 19-22.
159. Hartmann, A. and Frick, M. (1991) Münch. Med. Wochenschr. 133 (Suppl. 1), 23-25.
160. Mancini, M., Agozzino, B. and Bompani, R. (1993) Gazz. Med. Ital. Arch, Sci. Med. 152, 69-80.
161. Haase, A., Halama, P. and Hörr, R. (1996) Z. Gerontol. Geriat. 29, 302-309.
162. Maurer, K., Ihl, R., Dierks, T. et al. (1997) J. Psychiatr. Res. 31, 645-655.
163. Christie, J. E., Whalley, L. J., Bennie, J., Dick, H., Blackburn, I. M., Blackwood, D. H. R. and Fink, G. (1987) Br. J. Psychiat. 150, 674-681.
164. Schubert, H. and Halama, P. (1993) Geriatr. Forsch. 1, 45-53.
165. O'Brien, J. T., Ames, D. and Schweitzer, I. (1993) Int. J. Geriat. Psychiatry, 8, 887-898.
166. Sapolsky, R. M. (1996) Science, 273, 749-750.